This invention relates to the field of
traditional Chinese medicine preparation technology, and discloses a Qingfu Chaijin granule, its preparation method, and its application. The Qingfu Chaijin granule comprises the following
traditional Chinese medicine raw materials in parts by weight:
Bupleurum chinense 8-12 parts,
Cyperus rotundus 8-12 parts, Citrus reticulata peel 8-12 parts,
Salvia miltiorrhiza 12-18 parts,
Curcuma longa 8-12 parts,
Angelica sinensis 8-12 parts,
Ligusticum chuanxiong 5-8 parts,
Foeniculum vulgare 8-12 parts, Amethyst 25-35 parts,
Artemisia argyi 5-8 parts,
Cistanche deserticola 8-12 parts,
Epimedium brevicornu 8-12 parts, and
Rehmannia glutinosa 8-12 parts. The invention also discloses the application of the aforementioned Qingfuchaijin granules in the preparation of drugs for relieving or treating dysmenorrhea caused by qi stagnation and
blood stasis. By scientifically optimizing the compatibility ratio of Qingfuchaijin granules and combining it with a reasonable preparation
process design, the resulting Qingfuchaijin granules have been significantly improved in terms of stability, user experience, and performance. The use of dry
granulation or
spray drying-dry
granulation combined technology effectively reduces the initial
moisture content of the granules, significantly reduces the hygroscopicity of the granules, and improves the storage stability of the product.